{
  "id": 3822,
  "text": "1857.Rauh, L.A., Pannone, A.F.& Cantrell, L.A.Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?Gynecol Oncol (2017).1858.Salani, R., et al.Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1857.Rauh, L.A., Pannone, A.F.& Cantrell, L.A.Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?Gynecol Oncol (2017).1858.Salani, R., et al.Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据目前宫颈癌治疗后是否采用激素替代疗法的标准规范，通常取决于患者的具体情况，包括癌症分期、治疗类型以及患者的激素水平和症状。对于接受了卵巢切除或者放射治疗导致卵巢功能丧失的年轻患者，若确诊无宫颈癌复发或激素敏感性的肿瘤风险，慎重考虑激素替代疗法可以帮助缓解因雌激素缺乏导致的更年期症状，以及减少骨质疏松和心血管疾病的风险。\n\n激素替代疗法（HRT）的应用，需要严格遵循既定的临床指南，同时患者需进行详尽的风险评估，由专业医生指导。治疗过程中，应密切监测病情变化并定期随访，确保疗效最大化且副作用最小化。",
  "query": "宫颈癌治疗后，激素替代疗法的应用是否符合标准治疗规范？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌治疗后，激素替代疗法的应用是否符合标准治疗规范？\n\n<reference text>: 1857.Rauh, L.A., Pannone, A.F.& Cantrell, L.A.Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?Gynecol Oncol (2017).1858.Salani, R., et al.Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据目前宫颈癌治疗后是否采用激素替代疗法的标准规范，通常取决于患者的具体情况，包括癌症分期、治疗类型以及患者的激素水平和症状。对于接受了卵巢切除或者放射治疗导致卵巢功能丧失的年轻患者，若确诊无宫颈癌复发或激素敏感性的肿瘤风险，慎重考虑激素替代疗法可以帮助缓解因雌激素缺乏导致的更年期症状，以及减少骨质疏松和心血管疾病的风险。\n\n激素替代疗法（HRT）的应用，需要严格遵循既定的临床指南，同时患者需进行详尽的风险评估，由专业医生指导。治疗过程中，应密切监测病情变化并定期随访，确保疗效最大化且副作用最小化。"
}